References
- De Jongste JC, Shields MD. Cough 2: chronic cough in children. Thorax 2003; 58: 998–1003
- Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 24: S10–8
- Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115: 1422–7
- Versteegh FG, Weverling GJ, Peeters MF, Wilbrink B, Veenstra-van Schie MT, van Leeuwen-Gerritsen JM, et al. Community acquired pathogens associated with prolonged coughing in children: a prospective cohort study. Clin Microbiol Infect 2005; 11: 801–7
- Versteegh FG, Mertens PL, de Melker HE, Roord JJ, Schellekens JF, Teunis PF. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 2005; 133: 737–48
- www.who.int/immunization_standards/vaccine_quality/pq_suppliers/en/index.html Accessed on June 20, 2007.
- www.saglik.gov.tr: Accessed on March 7, 2007.
- Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J. Epidemiology of pertussis in French hospitals in 1993 and 1994: 30 y after a routine use of vaccination. Pediatr Infect Dis J 1998; 17: 412–8
- Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32: 1691–7
- Gilberg S, Njamkepo E, Du C, Partouche H, Gueirard P, Ghasarossian C, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole cell vaccine coverage. J Infect Dis 2002; 186: 415–8
- Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044–6
- Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000; 105: E31
- Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest 1999; 115: 1254–8
- Olin P, Gustafsson L, Rasmussen F. Efficacy trial of acellular pertussis vaccines: technical report trial II, with results of preplanned analysis of efficacy, immunogenicity and safety. Swedish Institute for Infectious Disease Control, Stockholm 1997
- World Health Organization Department of Vaccines and Biologicals. 2001. Pertussis surveillance: a global meeting. Geneva.
- www.cdc.gov/nip/publications/pertussis/guide.htm. Accessed on 7 March, 2007.
- Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicentre surveillance study. Pediatrics 1997; 100: E10
- Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, et al. European Sero-Epidemiology Network: standardization of the assay results for pertussis. Vaccine 2003; 22: 112–20
- Granstrom M, Granstrom G. Serological correlates in whooping cough. Vaccine 1993; 11: 445–8
- Granstrom G, Wretlind B, Salenstedt CR, Granstrom M. Evaluation of serological assays for diagnosis of whooping cough. J Clin Microbiol 1988; 26: 1818–23
- Dez-Domingo J, Ballester A, Baldo JM, Planelles MV, Villarroya JV, Alvarez T, et al. Incidence of pertussis in persons ≤15 y of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults. J Infect 2004; 49: 242–7
- Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 1999; 28(Suppl 2)S112–7
- Cimolai N, Trombley C, O'Neill D. Diagnosis of whooping cough: a new era with rapid molecular diagnostics. Pediatr Emerg Care 1996; 12: 91–3
- Deeks S, De SG, Boulianne N, Duval B, Rochette L, Dery P, et al. Failure of physicians to consider the diagnosis of pertussis in children. Clin Infect Dis 1999; 28: 840–6
- Couzigou C, Flahault A. Is pertussis being considered as a cause of persistent cough among adults?. Eur J Epidemiol 2003; 18: 1013–5
- Franco E, Giambi C, Ialacci R, Maurici M. Pertussis vaccination for adolescents and adults. Expert Opin Biol Ther 2004; 4: 1669–76
- Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-y community study. Br Med J 1988; 296: 612–4
- Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J. How to make sense of pertussis immunogencity data. Clin Infect Dis 2001; 33(Suppl 4)S288–91
- Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a 2-component acellular, a 5-component acellular, and a whole cell pertussis vaccine. N Engl J Med 1996; 334: 349–55
- Bremont F, Micheau P, Le RP, Brouard J, Pin I, Fayon M. Aetiology of chronic cough in children: analysis of 100 cases. Arch Pediatr 2001; 8(Suppl 3)645–9
- Hallander HO. Microbiological and serological diagnosis of pertussis. Clin Infect Dis 1999; 28(Suppl 2)S99–106
- Hu JJ, Lu CY, Chang LY, Huang CH, Chou CC, Huang FY, et al. Survey of pertussis in patients with prolonged cough. J Microbiol Immunol Infect 2006; 39: 54–8